Latest Diabetes: Drugs news
Bofanglutide Linked to Meaningful Reductions in HbA1c in Adults With T2DM
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Intranasal Insulin, Empagliflozin Have Promising Effects on Cognition
posted October 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM
posted August 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes
posted July 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Weight-Loss Surgery Produces Lasting Diabetes Remission
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy